These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 7560061)

  • 1. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
    Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
    J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyme borreliosis in transgenic mice tolerant to OspA from Borrelia burgdorferi 25015.
    Fikrig E; Barthold SW; Chen M; Tao H; Ali-Salaam P; Bockenstedt LK; Flavell RA
    J Infect Dis; 1997 Apr; 175(4):1000-3. PubMed ID: 9086169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
    Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R
    Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
    Das S; Barthold SW; Giles SS; Montgomery RR; Telford SR; Fikrig E
    J Clin Invest; 1997 Mar; 99(5):987-95. PubMed ID: 9062357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
    Comstedt P; Schüler W; Meinke A; Lundberg U
    PLoS One; 2017; 12(9):e0184357. PubMed ID: 28863166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis.
    Fikrig E; Bockenstedt LK; Barthold SW; Chen M; Tao H; Ali-Salaam P; Telford SR; Flavell RA
    J Infect Dis; 1994 Mar; 169(3):568-74. PubMed ID: 8158028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
    Probert WS; LeFebvre RB
    Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.
    Cassatt DR; Patel NK; Ulbrandt ND; Hanson MS
    Infect Immun; 1998 Nov; 66(11):5379-87. PubMed ID: 9784547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
    Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT; Burkot TR; Piesman J; Dolan MC; Capiau C; Hauser P; Dequesne G; Lobet Y
    Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ; Carner K; Liang X; Barbour AG
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Lyme borreliosis: route of inoculation determines immune response and infectivity.
    Pachner AR; Delaney E; Ricalton NS
    Reg Immunol; 1992; 4(6):345-51. PubMed ID: 1297405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of a novel vaccine for protection against Lyme borreliosis.
    Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
    PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.
    Dunne M; al-Ramadi BK; Barthold SW; Flavell RA; Fikrig E
    Infect Immun; 1995 Apr; 63(4):1611-4. PubMed ID: 7890431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ospA frame shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies.
    Fikrig E; Liu B; Fu LL; Das S; Smallwood JI; Flavell RA; Persing DH; Schoen RT; Barthold SW; Malawista SE
    J Immunol; 1995 Dec; 155(12):5700-4. PubMed ID: 7499856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W; Gern L; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of mice with lyme disease spirochetes constitutively producing outer surface proteins a and B.
    Strother KO; Hodzic E; Barthold SW; de Silva AM
    Infect Immun; 2007 Jun; 75(6):2786-94. PubMed ID: 17371860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.